penile squamous cell carcinoma and human papillomavirus Introduction The objective of this study was to to investigate the survival outcomes and prognostic factors of human papillomavirus (HPV) induced penile squamous cell carcinoma (pSCC). Penile squamous cell carcinoma (pSCC) is a rare malignancy with limited pathogenesis and carcinogenesis, and poor survival after standard treatment. They
Tag: oncology
Radiation therapy And VTE Risk
Radiation therapy And VTE Risk Thromboembolic events are often the primary cause of complications in malignancies. They also have a major effect on the morbidity and mortality of cancer patients. Compared to chemotherapy and other kinds of systemic therapies, there’s not enough data about the impact of ionizing radiation on the
Pseudouveitis with pancreatic carcinoma: a case study
Pseudouveitis with pancreatic carcinoma: a case study Overview of the Study This study is a report of a case of a 61- year- old man who presented with progressive deterioration of general condition with unilateral recurrent episodes of pseudouveitis presenting as non- granulomatous panuveitis of the left eye related to a choroidal
cancer prevention in rural communities
cancer prevention in rural communities This article examines cancer prevention outcomes using a developed community-based cancer registry. It also describes the methodology used to build and recruit to the registry. This comprehensive registry includes community participant profiles sorted by race/ethnicity and geography and presents preliminary insights about the distribution of known
skeletal muscle mass and cancer patient quality of life: a meta-analysis
skeletal muscle mass and cancer patient quality of life: a meta-analysis Loss of skeletal muscle mass (sarcopenia), is a widely prevalent problem among cancer patients with incidence ranging from 11 to 74%. Low skeletal muscle mass at baseline is predictive of poor cancer outcomes such as decreased overall survival, increased risk
incidence of secondary cancers after cirt vs rt
incidence of secondary cancers after cirt vs rt Overview of the Study The risk of secondary cancer after carbon-ion radiotherapy (CIRT) has not been well studied. In this study, the researchers assessed the incidence of secondary cancers in patients who have undergone CIRT for cervical cancer. Aside from CIRT, the researchers also
Filanesib combination therapy in multiple myeloma
Filanesib combination therapy in multiple myeloma Overview of the Study Filanesib is a kinesin spindle protein inhibitor that’s recently proposed as a cancer treatment for multiple myeloma. In this study of the first dose-escalation phase, the researchers tried to understand the maximum tolerated dose of two schedules of filanesib, bortezomib, and dexamethasone
pediatric leukemia patients utilizing levofloxacin
pediatric leukemia patients utilizing levofloxacin STUDY BACKGROUND Bacterial infection-related morbidity and mortality are high in children treated for acute myeloid leukemia (AML) and relapsed acute lymphoblastic leukemia (rALL). Bacteremia not only contributes to mortality but also prolongs hospitalization, delays chemotherapy, decreases the quality of life, and requires the administration of costly and
Breast Cancer And An Analysis of Cardiovascular Events
Breast Cancer And An Analysis of Cardiovascular Events Breast cancer is considered one of the most common cancers in the world. In 2020, there are 7.8 million women diagnosed with breast cancer globally. It also has resulted in more than 700,000 deaths based on the data from WHO. Unlike other cancers
Monotherapy Or Chemotherapy Adjunct: Pembrolizumab In Advanced NSCLC
Monotherapy Or Chemotherapy Adjunct: Pembrolizumab In Advanced NSCLC Objectives To assess the effectiveness and safety of pembrolizumab monotherapy and in combination with chemotherapy in patients with advanced non–small-cell lung cancer (NSCLC). Introduction Historically, patients with advanced NSCLC have a poor prognosis despite the use of platinum-based chemotherapy drugs. The 5-year relative survival rate of
